{"id":"https://openalex.org/W2010666299","doi":"https://doi.org/10.1212/wnl.78.1_meetingabstracts.p04.153","title":"A Pilot Trial of Zinc in Patients with ALS (P04.153)","display_name":"A Pilot Trial of Zinc in Patients with ALS (P04.153)","publication_year":2012,"publication_date":"2012-04-22","ids":{"openalex":"https://openalex.org/W2010666299","doi":"https://doi.org/10.1212/wnl.78.1_meetingabstracts.p04.153","mag":"2010666299"},"language":"nl","primary_location":{"id":"doi:10.1212/wnl.78.1_meetingabstracts.p04.153","doi":"https://doi.org/10.1212/wnl.78.1_meetingabstracts.p04.153","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.78.1_meetingabstracts.p04.153","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113439377","display_name":"T. Levine","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152094","display_name":"PNA Center for Neurological Research","ror":"https://ror.org/04nt88t73","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210152094"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T. Levine","raw_affiliation_strings":["PNA Center for Neurological Research Phoenix AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PNA Center for Neurological Research Phoenix AZ","institution_ids":["https://openalex.org/I4210152094"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070845239","display_name":"Nicole C. Hank","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152094","display_name":"PNA Center for Neurological Research","ror":"https://ror.org/04nt88t73","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210152094"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"N. Hank","raw_affiliation_strings":["PNA Center for Neurological Research Phoenix AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PNA Center for Neurological Research Phoenix AZ","institution_ids":["https://openalex.org/I4210152094"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025085620","display_name":"David Saperstein","orcid":"https://orcid.org/0000-0003-3448-0607","observed_orcids":["https://orcid.org/0000-0003-3448-0607"]},"institutions":[{"id":"https://openalex.org/I4210152094","display_name":"PNA Center for Neurological Research","ror":"https://ror.org/04nt88t73","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210152094"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Saperstein","raw_affiliation_strings":["PNA Center for Neurological Research Phoenix AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PNA Center for Neurological Research Phoenix AZ","institution_ids":["https://openalex.org/I4210152094"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065806824","display_name":"Walter G. Bradley","orcid":"https://orcid.org/0000-0002-1085-5040","observed_orcids":["https://orcid.org/0000-0002-1085-5040"]},"institutions":[{"id":"https://openalex.org/I145608581","display_name":"University of Miami","ror":"https://ror.org/02dgjyy92","country_code":"US","type":"education","lineage":["https://openalex.org/I145608581"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W. Bradley","raw_affiliation_strings":["University of Miami ,  Miami, FL ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Miami ,  Miami, FL ,","institution_ids":["https://openalex.org/I145608581"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018425320","display_name":"Paul Alan Cox","orcid":"https://orcid.org/0000-0001-6401-2981","observed_orcids":["https://orcid.org/0000-0001-6401-2981"]},"institutions":[{"id":"https://openalex.org/I4210122304","display_name":"Institute for EthnoMedicine","ror":"https://ror.org/02rrpz836","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210122304"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. Cox","raw_affiliation_strings":["Institute for Ethnomedicine Jackson WY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Ethnomedicine Jackson WY","institution_ids":["https://openalex.org/I4210122304"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"78","issue":"Meeting Abstracts 1","first_page":"P04.153","last_page":"P04.153"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10855","display_name":"Amyotrophic Lateral Sclerosis Research","score":0.9448000192642212,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10855","display_name":"Amyotrophic Lateral Sclerosis Research","score":0.9448000192642212,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10915","display_name":"Trace Elements in Health","score":0.03790000081062317,"subfield":{"id":"https://openalex.org/subfields/2916","display_name":"Nutrition and Dietetics"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10790","display_name":"Heavy Metal Exposure and Toxicity","score":0.004000000189989805,"subfield":{"id":"https://openalex.org/subfields/2307","display_name":"Health, Toxicology and Mutagenesis"},"field":{"id":"https://openalex.org/fields/23","display_name":"Environmental Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/amyotrophic-lateral-sclerosis","display_name":"amyotrophic lateral sclerosis","score":0.9700000286102295},{"id":"https://openalex.org/keywords/zinc-supplementation","display_name":"zinc supplementation","score":0.8679999709129333},{"id":"https://openalex.org/keywords/zinc-methionine","display_name":"zinc methionine","score":0.9760000109672546},{"id":"https://openalex.org/keywords/bmaa","display_name":"BMAA","score":0.8539999723434448},{"id":"https://openalex.org/keywords/glutamate","display_name":"glutamate","score":0.6809999942779541},{"id":"https://openalex.org/keywords/neurotoxicity","display_name":"neurotoxicity","score":0.8270000219345093},{"id":"https://openalex.org/keywords/copper","display_name":"copper","score":0.5120000243186951},{"id":"https://openalex.org/keywords/drug-safety-and-tolerability","display_name":"drug safety and tolerability","score":0.7509999871253967},{"id":"https://openalex.org/keywords/alsfrs-r","display_name":"ALSFRS-R","score":0.7789999842643738},{"id":"https://openalex.org/keywords/disease-progression","display_name":"disease progression","score":0.6209999918937683}],"concepts":[{"id":"https://openalex.org/C535196362","wikidata":"https://www.wikidata.org/wiki/Q758","display_name":"Zinc","level":2,"score":0.8579023480415344},{"id":"https://openalex.org/C2779491297","wikidata":"https://www.wikidata.org/wiki/Q3338704","display_name":"Neurotoxicity","level":3,"score":0.7348946332931519},{"id":"https://openalex.org/C2779319286","wikidata":"https://www.wikidata.org/wiki/Q415744","display_name":"Riluzole","level":4,"score":0.6684283018112183},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6538740992546082},{"id":"https://openalex.org/C61174792","wikidata":"https://www.wikidata.org/wiki/Q420510","display_name":"Glutamate receptor","level":3,"score":0.6026943325996399},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5706428289413452},{"id":"https://openalex.org/C2778290051","wikidata":"https://www.wikidata.org/wiki/Q10724674","display_name":"Zinc toxicity","level":3,"score":0.5390322804450989},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.46849948167800903},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4221954345703125},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.41358980536460876},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3641749620437622},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3580288290977478},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.33633875846862793},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1212/wnl.78.1_meetingabstracts.p04.153","doi":"https://doi.org/10.1212/wnl.78.1_meetingabstracts.p04.153","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.78.1_meetingabstracts.p04.153","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4408467100","https://openalex.org/W2785903820","https://openalex.org/W2336926079","https://openalex.org/W7055615355","https://openalex.org/W2079473845","https://openalex.org/W2161248259","https://openalex.org/W2767188313","https://openalex.org/W2982212650","https://openalex.org/W7065545099","https://openalex.org/W2066825972"],"abstract_inverted_index":{"Objective:":[0],"To":[2],"determine":[3],"the":[4,40,45,70,120,126,202,220,226,249,257,268],"safety":[5,176,290],"and":[6,19,27,84,107,123,153,162,171,179,191,217,270,295,324,346],"tolerability":[7],"of":[8,23,58,104,142,219,234,251,265,300],"zinc":[9,64,91,178,301],"methionine":[10],"(Optizinc)":[11],"at":[12,69,149,169,172,189,192,208,280],"high":[13,102],"doses":[14,141],"in":[15,25,112,229,242,285,302],"patients":[16,100,134,200,205,254,286],"with":[17,116,136,287,304,321,340],"ALS":[18,47,138,235,305],"to":[20,53,75,79,90,101,246,260,330,354,360],"measure":[21],"levels":[22,103,182,212,222],"BMAA":[24,49,85,106,167,266],"blood":[26,269],"urine.":[28],"Background":[31],"Previous":[33],"studies":[34],"have":[35],"identified":[36],"\u03b2-methylamino-L-alanine":[37],"(BMAA),":[38],"as":[39,65,237],"potential":[41,67,121],"neurotoxin":[42],"responsible":[43],"for":[44,158,166,319,338],"Guamanian":[46],"complex.":[48],"has":[50,315,328,334,352,358],"been":[51],"shown":[52],"be":[54,87,110,307],"an":[55],"avid":[56],"binder":[57],"zinc.":[59],"Interestingly,":[60],"glutamate":[61,83,108],"also":[62],"requires":[63],"a":[66,80,113],"modulator":[68],"synapse.":[71],"This":[72,289],"competitive":[73],"binding":[74],"Zinc":[76,211],"could":[77,86],"lead":[78],"state":[81],"where":[82],"left":[88],"unbound":[89],"increasing":[92],"their":[93],"neurotoxicity.":[94],"We":[95],"hypothesize":[96],"that":[97,293],"by":[98,239],"exposing":[99],"zinc,":[105,117],"would":[109],"kept":[111],"bound":[114],"complex":[115],"thereby":[118],"decreasing":[119],"neurotoxicity":[122],"slowing":[124],"down":[125],"disease":[127],"course.":[128],"Design/Methods:":[131],"10":[133],"diagnosed":[135],"sporadic":[137],"on":[139,262],"stable":[140],"riluzole":[143],"were":[144,164,183,213,223],"enrolled.":[145],"Patients":[146],"received":[147,316,335],"Optizinc":[148,207,279],"30":[150],"mg":[151,156],"TID":[152],"copper":[154,180],"2":[155],"QD":[157],"three":[159],"months.":[160],"Blood":[161],"urine":[163,271],"collected":[165],"analysis":[168],"baseline":[170,190],"month":[173,193],"3.":[174,194],"ALSFRSR,":[175],"labs,":[177],"plasma":[181],"measured":[184,188,238],"monthly.":[185],"FVC":[186],"was":[187,282],"Results:":[197],"Eight":[199],"completed":[201,256],"study.":[203],"All":[204,253],"tolerated":[206,284],"90":[209],"mg/d.":[210],"maintained":[214,224],"between":[215],"80%":[216],"125%":[218],"ULN.Copper":[221],"within":[225],"normal":[227],"range":[228],"all":[230],"patients.":[231],"The":[232],"rate":[233],"progression,":[236],"monthly":[240],"change":[241],"ALS-FRS-R":[243],"scores,":[244],"seemed":[245],"improve":[247],"over":[248],"course":[250],"treatment.":[252,263],"who":[255],"study":[258,291,299],"opted":[259],"stay":[261],"Levels":[264],"from":[267],"are":[272],"being":[273],"analyzed.":[274],"Conclusions:":[277],"90mg/d":[281],"well":[283],"ALS.":[288],"suggests":[292],"larger":[294],"longer":[296],"placebo":[297],"conrolled":[298],"patient":[303],"should":[306],"performed.":[308],"Disclosure:":[311],"Dr.":[313,326,332,350,356],"Levine":[314],"personal":[317,336],"compensation":[318,337],"activities":[320,339],"Lilly,":[322,345],"Pfizer,":[323],"Talecris.":[325],"Hank":[327],"nothing":[329,353,359],"disclose.":[331,355,361],"Saperstein":[333],"Talecris,":[341],"CSL":[342],"Behring,":[343],"Eli":[344],"Corinthian":[347],"Reference":[348],"Lab.":[349],"Bradley":[351],"Cox":[357]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}